IJPR  artciles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016). 

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
FREQUENCY OF DEPRESSION AND ANXIETY IN PATIENTS UNDERGOING METHAD ONE MAINTENANCE THERAPY AT DRUG REHABILITATION CENTERS OF RASHT

Author: MAHNAZFALLAHIKHESHTMASJEDI, ROBABEHSOLEIMANI, ELAHEHABDOLLAHI
Abstract: Given the anxiety and depression of addicts who are quitting drug abuse and the effects of these disorders on the treatment process. The purpose of this study was to investigate of frequency and risk factors of depression and anxiety in patients undergoing methadone maintenance therapy (MMT) at drug rehabilitation centers of Rasht, Northern Iran. This is a, cross-sectional study that uses a random cluster sampling method. The study population included 446 people with substance abuse in Rasht who were receiving methadone maintenance treatment in 2016. The instruments used in this study are demographic questionnaires, Hamilton Rating Scale for Depression (HAM-D), Hamilton Rating Scale for Anxiety (HAM-A), and Brief Psychiatric Rating Scale (BPRS). After the data were collected, they were analyzed by SPSS 22.Out of 446 patients using methadone, 72% had depression symptoms, and 67.3% showed anxiety symptoms. There was a significant correlation between the depression and anxiety scores of Hamilton’s scales and that of BPRS in terms of methadone maintenance treatment among male, married, rural, and low education. There was also a significant relationship (P= 0.001) between the mean scores of HAM-A and HAM-D with the type of substance used. A significant correlation, was seen between the mean scores of HAM-A, HAM-D and BPRS in patients undergoing methadone maintenance therapy. Thus, with the increase in depression and anxiety, psychiatric symptoms also intensify. It is recommended that people receiving alternative therapies such as methadone undergo screening and be attended to in terms of anxiety and depression symptoms.
Keyword: Depression, anxiety, dependency, methadone
EOI: http://eoi.citefactor.org/10.11209/ijpr.10.03
DOI: https://doi.org/10.31838/ijpr/2018.10.03.051
Download: Request For Article
 












USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477